Xenon Pharmaceuticals Inc. (XENE) stock analysis
XENE · Xenon Pharmaceuticals Inc.
Latest recorded price: USD 39.26
Sector and industry: Healthcare · Biotechnology
Fiscal 2018 figures: revenue growth -72.9%, free cash flow margin -11,328.3%. The model flags 1 risk signal for this company (1 high severity).